Citi Pharma Limited (PSX:CPHL)

Citi Pharma Revenue

In the fiscal year ending June 30, 2025, Citi Pharma had annual revenue of 13.15B PKR with 6.00% growth. Citi Pharma had revenue of 3.05B in the quarter ending June 30, 2025, with 6.24% growth.

• Revenue: 13.15B
• Revenue Growth: +6.00%
• P/S Ratio: 1.58
• Revenue / Employee: 24.77M
• Employees: 531
• Market Cap: 20.84B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	13.15B	744.28M	6.00%
Jun 30, 2024	12.41B	12.26M	0.10%
Jun 30, 2023	12.40B	2.62B	26.76%
Jun 30, 2022	9.78B	3.98B	68.75%
Jun 30, 2021	5.80B	2.27B	64.29%